Cargando…
Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
In the central nervous system diseases, glioma is one of the most common malignancies around the world. Despite the recent improvements in therapies for glioma, the prognosis of some high‐risk glioma remains poor. In glioma, isoliquiritigenin (ISL) is reported to have antioxidative and antitumor act...
Autores principales: | Liu, Aiqun, Jiang, Baohong, Song, Cailu, Zhong, Qizhi, Mo, Yufan, Yang, Ruiqin, Chen, Ciyu, Peng, Cheng, Peng, Fu, Tang, Hailin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220153/ https://www.ncbi.nlm.nih.gov/pubmed/37250146 http://dx.doi.org/10.1002/mco2.282 |
Ejemplares similares
-
circ_0030018 promotes glioma proliferation and metastasis
por: Shao, Yun, et al.
Publicado: (2021) -
Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2017) -
Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development
por: Peng, Fu, et al.
Publicado: (2020) -
Author Correction: Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2023) -
The circular RNA circ_0030018/miR-136/migration and invasion enhancer 1 (MIEN1) axis promotes the progression of polycystic ovary syndrome
por: Xu, Jing, et al.
Publicado: (2022)